Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy
Abstract Background Neoadjuvant chemotherapy (NAC) has become the standard of care for resectable esophageal squamous cell carcinoma (ESCC) which is one of the most lethal cancers, to improve resectability and prognosis. On this basis, to provide individually optimized therapy for ESCC, a minimally-...
Main Authors: | Yukiko Niwa, Suguru Yamada, Fuminori Sonohara, Keisuke Kurimoto, Masamichi Hayashi, Mitsuru Tashiro, Naoki Iwata, Mitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-018-1762-6 |
Similar Items
-
PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma
by: Keisuke Kurimoto, et al.
Published: (2017-10-01) -
Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis
by: Mitsuro Kanda, et al.
Published: (2019-10-01) -
Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
by: Shinichi Umeda, et al.
Published: (2017-09-01) -
Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
by: Nana Kimura, et al.
Published: (2020-12-01) -
Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer
by: Takehiro Okabayashi, et al.
Published: (2022-11-01)